ZYNEX INC (ZYXI) Stock Price & Overview

NASDAQ:ZYXIUS98986M1036

Current stock price

0.125 USD
-0.07 (-34.9%)
At close:
0.13 USD
+0.01 (+4%)
After Hours:

The current stock price of ZYXI is 0.125 USD. Today ZYXI is down by -34.9%. In the past month the price decreased by -82.88%. In the past year, price decreased by -98.48%.

ZYXI Key Statistics

52-Week Range0.1247 - 8.45
Current ZYXI stock price positioned within its 52-week range.
1-Month Range0.1247 - 2.1
Current ZYXI stock price positioned within its 1-month range.
Market Cap
3.799M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-1.41
Dividend Yield
N/A

ZYXI Stock Performance

Today
-34.9%
1 Week
-63.25%
1 Month
-82.88%
3 Months
-91.38%
Longer-term
6 Months -95.10%
1 Year -98.48%
2 Years -98.85%
3 Years -99.10%
5 Years -98.98%
10 Years N/A

ZYXI Stock Chart

ZYNEX INC / ZYXI Daily stock chart

ZYXI Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to ZYXI. When comparing the yearly performance of all stocks, ZYXI is a bad performer in the overall market: 99.82% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

ZYXI Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to ZYXI. ZYXI may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ZYXI Earnings

On November 17, 2025 ZYXI reported an EPS of -0.4 and a revenue of 13.36M. The company missed EPS expectations (-124.09% surprise) and missed revenue expectations (-43.09% surprise).

Next Earnings DateMar 9, 2026
Last Earnings DateNov 17, 2025
PeriodQ3 / 2025
EPS Reported-$0.40
Revenue Reported13.36M
EPS Surprise -124.09%
Revenue Surprise -43.09%

ZYXI Forecast & Estimates

8 analysts have analysed ZYXI and the average price target is 2.91 USD. This implies a price increase of 2225.6% is expected in the next year compared to the current price of 0.125.

For the next year, analysts expect an EPS growth of -1584.67% and a revenue growth -52.33% for ZYXI


Analysts
Analysts82.5
Price Target2.91 (2228%)
EPS Next Y-1584.67%
Revenue Next Year-52.33%

ZYXI Groups

Sector & Classification

Index Membership

ZYXI Financial Highlights

Over the last trailing twelve months ZYXI reported a non-GAAP Earnings per Share(EPS) of -1.41. The EPS decreased by -540.63% compared to the year before.


Income Statements
Revenue(TTM)108.20M
Net Income(TTM)-73.96M
Industry RankSector Rank
PM (TTM) N/A
ROA -163.18%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%-671.43%
Sales Q2Q%-73.26%
EPS 1Y (TTM)-540.63%
Revenue 1Y (TTM)-44.13%

ZYXI Ownership

Ownership
Inst Owners13.71%
Shares30.39M
Float15.75M
Ins Owners47.94%
Short Float %N/A
Short RatioN/A

About ZYXI

Company Profile

ZYXI logo image Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. The company is headquartered in Englewood, Colorado and currently employs 1,000 full-time employees. The company went IPO on 2002-11-27. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave, M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Private Labeled Rehabilitation Products, which include Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces, Bracing (Knee and Wrist), and Dynacomp, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter.

Company Info

IPO: 2002-11-27

ZYNEX INC

9655 Maroon Circle

Englewood COLORADO 80112 US

CEO: Thomas Sandgaard

Employees: 1000

ZYXI Company Website

ZYXI Investor Relations

Phone: 18004956670

ZYNEX INC / ZYXI FAQ

What does ZYNEX INC do?

Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. The company is headquartered in Englewood, Colorado and currently employs 1,000 full-time employees. The company went IPO on 2002-11-27. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave, M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Private Labeled Rehabilitation Products, which include Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces, Bracing (Knee and Wrist), and Dynacomp, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter.


What is the current price of ZYXI stock?

The current stock price of ZYXI is 0.125 USD. The price decreased by -34.9% in the last trading session.


Does ZYNEX INC pay dividends?

ZYXI does not pay a dividend.


What is the ChartMill technical and fundamental rating of ZYXI stock?

ZYXI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


On which exchange is ZYXI stock listed?

ZYXI stock is listed on the Nasdaq exchange.


What is the Price/Earnings (PE) ratio of ZYNEX INC (ZYXI)?

ZYNEX INC (ZYXI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.41).


What is the market capitalization of ZYXI stock?

ZYNEX INC (ZYXI) has a market capitalization of 3.80M USD. This makes ZYXI a Nano Cap stock.